* Is there ANY known route/firmware quirk to recover sub-second wake phase in ActiGraph GT3X+ devices?
* With 0.3–0.8s timing noise, which coupling metrics cleanly separate true lagged coordination from jittered simultaneous co-movement?
* Other non-circular anchor ideas?
* Is there ANY known route/firmware quirk to recover sub-second wake phase in ActiGraph GT3X+ devices?
* With 0.3–0.8s timing noise, which coupling metrics cleanly separate true lagged coordination from jittered simultaneous co-movement?
* Other non-circular anchor ideas?
#rstats
https://cran.r-project.org/package=actiRhythm
#rstats
https://cran.r-project.org/package=actiRhythm
#rstats
https://cran.r-project.org/package=actiread
#rstats
https://cran.r-project.org/package=actiread
#rstats
https://cran.r-project.org/package=actigraph.sleepr
#rstats
https://cran.r-project.org/package=actigraph.sleepr
#rstats
https://cran.r-project.org/package=stepmetrics
#rstats
https://cran.r-project.org/package=stepmetrics
#rstats
https://cran.r-project.org/package=activityCounts
#rstats
https://cran.r-project.org/package=activityCounts
academic.oup.com/sleepadvance...
academic.oup.com/sleepadvance...
根据发表在《The British Journal of Sports Medicine》期刊上的一项研究,Mass General Brigham 的研究人员分析了 13,547 名年长女性一周的步行数和十年内的死亡率和心血管疾病发病率,发现每周一到两天步行数达到 4,000 步与更低的死亡和心血管疾病风险相关——步数越多,益处越大,直至风险降低至一定水平。这些女性的平均年龄是 71.8 岁,她们在 2011 年至 2015 年间佩戴 ActiGraph GT3X+ 加速度计追踪一周的步数。根据每周步行数她们被分成 4,00
根据发表在《The British Journal of Sports Medicine》期刊上的一项研究,Mass General Brigham 的研究人员分析了 13,547 名年长女性一周的步行数和十年内的死亡率和心血管疾病发病率,发现每周一到两天步行数达到 4,000 步与更低的死亡和心血管疾病风险相关——步数越多,益处越大,直至风险降低至一定水平。这些女性的平均年龄是 71.8 岁,她们在 2011 年至 2015 年间佩戴 ActiGraph GT3X+ 加速度计追踪一周的步数。根据每周步行数她们被分成 4,00
📉 IMI project MOBILISE-D's algorithms translate walking patterns into indicators to track changes in disease status
✅ Companies are using the public algorithms in their products
👉 europa.eu/!GFFHYt
#IHITransformingHealth #IHISummerOfScience #HorizonEU
📉 IMI project MOBILISE-D's algorithms translate walking patterns into indicators to track changes in disease status
✅ Companies are using the public algorithms in their products
👉 europa.eu/!GFFHYt
#IHITransformingHealth #IHISummerOfScience #HorizonEU
4/5
4/5
ActiGraph’s recent acquisition is a big step for innovators leveraging #digitalhealth tools to make #clinicaltrials more patient-centric and accessible: bit.ly/40pR7VK
#futureofhealthcare #wearables #rpm
ActiGraph’s recent acquisition is a big step for innovators leveraging #digitalhealth tools to make #clinicaltrials more patient-centric and accessible: bit.ly/40pR7VK
#futureofhealthcare #wearables #rpm